FDA Approves Barhemsys (amisulpride) for the Treatment and Prevention of PONV

Cambridge, UK and Indianapolis, US– 27 February 2020: Acacia Pharma Group plc (“Acacia Pharma” or the“Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialization of...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news